Tslp

Tuesday, 24 February 2026

Latest News for: tslp

Edit

Aclaris Therapeutics Announces Positive Interim Results of Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 ...

Nasdaq Globe Newswire 06 Jan 2026

Aclaris Therapeutics Announces Positive Interim Results of Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 ... .

Edit

Aclaris Therapeutics Announces Positive Interim Results of Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Supporting Expedited Clinical Development (Form 8-K) (Aclaris Therapeutics Inc)

Public Technologies 06 Jan 2026

Aclaris Therapeutics Announces Positive Interim Results of Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Supporting Expedited Clinical Development ... IL-4 and TSLP stimulated CCL17/TARC.

Edit

Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13

Nasdaq Globe Newswire 22 Dec 2025

... QX027N), a potential best-in-disease, long-acting bispecific antibody targeting TSLP and IL-13.

Edit

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe ...

Canada Newswire 01 Dec 2025

GB-0895 is an investigational, long-acting monoclonal antibody engineered with AI to target thymic stromal lymphopoietin (TSLP), a key driver of airway inflammation ... TSLP for at least six months.

Edit

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

PR Newswire 01 Dec 2025

These are the first global Phase 3 studies of a long-acting anti-TSLP antibody, marking a pivotal step as GB-0895 advances the promise of programmable biology ... TSLP for at least six months.

Edit

TSLP Inhibitors and TSLP Receptor Antagonists Competitor Analysis Report 2025: Early R&D in Tezspire Biosimilars ...

Nasdaq Globe Newswire 27 Nov 2025

Key market opportunities include expanding TSLP inhibitors and receptor antagonists beyond severe asthma ...

Article Search

tools

You can search using any combination of the items listed below.

Language:

Sort:

Indexed:

Search:

Duplicates:

Podcasts:

Latest News for: tslp

Aclaris Therapeutics Announces Positive Interim Results of Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 ...

Aclaris Therapeutics Announces Positive Interim Results of Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Supporting Expedited Clinical Development (Form 8-K) (Aclaris Therapeutics Inc)

Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe ...

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

TSLP Inhibitors and TSLP Receptor Antagonists Competitor Analysis Report 2025: Early R&D in Tezspire Biosimilars ...

Article Search

EXPLORE WN.com